-
Israel shows a Dip in Pfizer Vaccine Efficacy
The vaccine’s efficacy against illness was reported to drop from 94% to 64% based on data from June 6 through early July. Protection remained high against severe disease.
https://www.ajmc.com/view/what-we-re-reading-rural-ambulance-services-updated-pfizer-vaccine-efficacy-in-israel-340b-drug-payment-cuts -
Officials Say No Booster Shots Needed
Following a meeting with Pfizer, HHS officials say fully vaccinated individuals do not need a COVID-19 vaccine booster shot. At this point, no data have suggested a significant waning of vaccine efficacy or an increase in infections among those fully vaccinated.
https://www.ajmc.com/view/what-we-re-reading-vaccine-booster-shot-rare-nerve-syndrome-warning-pesticide-linked-to-brain-damage-in-children -
CDC Recommends Pregnant People Get Vaccinated
The CDC now urges all mothers-to-be to get vaccinated against COVID-19 in light of rising numbers of hospitalizations among unvaccinated expecting people.
https://www.ajmc.com/view/what-we-re-reading-fda-to-authorize-third-dose-for-immunocompromised-cdc-encourages-vaccine-during-pregnancy-fda-rejects-anemia-drug -
Booster Shot Endorsed for Immunocompromised
The CDC’s Advisory Committee on Immunization Practices (ACIP) votes 11-0 to recommend a 3rd dose of a Pfizer or Moderna mRNA vaccine for immunocompromised individuals, 1 day after the FDA approved the dose for people who have received organ transplants or have other conditions that have damaged their immune systems. There are around 7 million immunocompromised people in the United States.
https://www.ajmc.com/view/cdc-advisory-committee-to-meet-to-discuss-booster-shot-for-immunocompromised -
Health Officials Announce Plan for Booster Shots in General Public
US health officials announced a plan for any American over the age of 18 who received a COVID-19 vaccine to become eligible for a booster shot 8 months following their second dose of an mRNA vaccine, beginning on September 20, 2021
https://www.ajmc.com/view/health-officials-lay-out-plan-for-us-covid-19-booster-shots-in-general-public -
Pfizer/BioNTech Vaccine Gains Full FDA Approval
The FDA grants full authorization to the Pfizer/BioNTech vaccine for individuals aged 16 and older, while some experts hope the news will convince vaccine holdouts to get immunized. Those aged 12 to 15 can still receive the vaccine under the initial EUA.
https://www.ajmc.com/view/pfizer-covid-19-vaccine-gains-full-fda-approval -
Israel Data Supports Booster Shot Efficacy
Data from Israel show that adults aged 60 and older who received the 3rd dose of an mRNA vaccine had significantly improved protection against infection and severe illness compared with those who received 2 shots.
https://www.ajmc.com/view/what-we-re-reading-booster-shot-effective-climate-change-impact-on-farmworkers-uninsured-totals-amid-pandemic -
Vaccine Mandates Announced
Following the FDA’s full approval of the Pfizer/BioNTech vaccine, several large organizations, including Disney, issues vaccination mandates for workers. President Biden has also urged private employers to issue similar mandates.
https://www.ajmc.com/view/what-we-re-reading-expanding-pediatric-vaccine-authorization-pfizer-approval-spurs-vaccine-mandates-sedentary-behavior-stroke-risk-linked -
Johnson & Johnson Releases Booster Shot Data
A booster dose of the J&J vaccine dramatically increases individuals’ levels of antibodies against COVID-19, according to a company report, while studies indicate higher levels of antibodies are linked with higher rates of protection. -
Pfizer Plans to Roll Out Boosters Starting September 20
White House Chief Medical Advisor Anthony Fauci, MD, says wide distribution of Pfizer’s booster shot against COVID-19 is expected to begin the week of September 20, although the plan still needs approval from public health officials.
https://www.ajmc.com/view/what-we-re-reading-doj-to-protect-abortion-access-pfizer-booster-distribution-announced-eviction-covid-19-risk-linked -
Los Angeles Schools Mandate Vaccines
The city’s board of education approved a measure requiring all children aged 12 and older to be vaccinated against COVID-19. The move marks the first such mandate among one of the nation’s largest school systems, which currently tests all students and employees for COVID-19 each week.
https://www.ajmc.com/view/dr-deepak-bhatt-on-the-importance-of-in-hospital-initiation-of-sglt2-inhibitors -
Expert Review: Boosters Not Needed Among General Public
Published in The Lancet, an expert review of scientific evidence concluded booster doses of COVID-19 vaccines are not needed for the general public at this time, as vaccines in the United States continue to provide highly effective protection against severe disease and hospitalization caused by the delta variant.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)02046-8/fulltext -
FDA Committee Votes Against Boosters for General Public
An advisory committee voted against boosters for those in the United States aged 16 and older but endorsed a measure to provide boosters to people 65 years and older or who are at a high risk of severe COVID-19.
https://www.statnews.com/2021/09/23/covid19-vaccine-boosters-cdc-acip/#:~:text=The%20FDA's%20vaccine%20advisory%20committee,had%20received%20the%20Pfizer%20vaccine. -
Pfizer Says Vaccine Is Safe, Effective in Children
Pfizer and BioNTech announce in a press release that a new formulation of the companies’ vaccine is safe for use in children aged 5 to 11 years. Data have not yet been released or peer reviewed and are based on a clinical trial assessing the efficacy of one-third of the approved adult dose.
https://www.businesswire.com/news/home/20210920005452/en/Pfizer-and-BioNTech-Announce-Positive-Topline-Results-From-Pivotal-Trial-of-COVID-19-Vaccine-in-Children-5-to-11-Years -
J&J Announce Efficacy of 2-Dose Vaccine
A 2-dose version of J&J's COVID-19 vaccine has comparable efficacy to the 2-dose regimens from Pfizer/BioNTech and Moderna. J&J released data that the 2-dose vaccine provided 94% protection against symptomatic infection.
https://www.cnn.com/2021/09/21/health/johnson-vaccine-two-doses-booster/index.html -
Where do I think this is going
I think think this will keep going how it is as of right now. That meaning I think they will keep pushing people to get the vaccine and if there is a new mutation of covid they will come out with another booster for you to get in order to keep you safe from that as well. I think it will be a while before it completely ends but it will slowly fizzle out over time people have just stopped caring anymore.